| 1 | MRK | Merck & Co., Inc. | 8.27% |
| 2 | JNJ | Johnson & Johnson | 8.06% |
| 3 | BMY | Bristol-Myers Squibb Company | 7.41% |
| 4 | PFE | Pfizer Inc. | 6.48% |
| 5 | ABBV | AbbVie Inc. | 6.31% |
| 6 | VTRS | Viatris Inc. | 4.37% |
| 7 | BIIB | Biogen Inc. | 4.24% |
| 8 | CAH | Cardinal Health, Inc. | 4.22% |
| 9 | LLY | Eli Lilly and Company | 4.14% |
| 10 | REGN | Regeneron Pharmaceuticals, Inc. | 3.94% |
| 11 | GILD | Gilead Sciences, Inc. | 3.92% |
| 12 | AMGN | Amgen Inc. | 3.71% |
| 13 | VRTX | Vertex Pharmaceuticals Incorporated | 3.47% |
| 14 | UTHR | United Therapeutics Corporation | 3.11% |
| 15 | ZTS | Zoetis Inc. | 2.34% |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 2.28% |
| 17 | ILMN | Illumina, Inc. | 1.66% |
| 18 | INCY | Incyte Corporation | 1.49% |
| 19 | PTCT | PTC Therapeutics, Inc. | 1.47% |
| 20 | EXEL | Exelixis, Inc. | 1.24% |
| 21 | CRL | Charles River Laboratories International, Inc. | 1.14% |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 1.12% |
| 23 | ELAN | Elanco Animal Health Incorporated | 1.12% |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 1.02% |
| 25 | HALO | Halozyme Therapeutics, Inc. | 0.85% |
| View FTXH holdings |
